New Ebola vaccine trial launches as outbreak spreads in DR Congo

Results may be months away, but efforts are advancing towards enhanced treatment and the world’s first vaccine for the Bundibugyo species of Ebola, the World Health Organization (WHO) said on Tuesday as deaths and cases rise in the largest ever outbreak on record in the Democratic Republic of the Congo (DRC).

3,748 cases, including 1,657 deaths and 708 recoveries, as of 1 August, according to WHO

While Ebola vaccines exist, trials for the first ever Bundibugyo species-specific candidate vaccine began in the UK on 24 July, with a second starting in Canada this week

Clinical trials of medicine and treatment options are rolling out in Ituri province, the restive epicentre of the current outbreak

Bold News stores the normalized extraction for evidence and analysis. This public wrapper shows a limited excerpt; use the original link for the publisher's complete presentation.